Kairos Pharma Announces 1-For-7 Reverse Stock Split, Effective Sept. 1
Kairos Pharma, Ltd. (NYSE:KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced that it will conduct a reverse stock split of its outstanding shares of common
Kairos Pharma is combining seven old shares into one new share on September 1st—the number of shares you own will shrink, but each share's price should go higher. When companies do this, it often means they're trying to meet stock-exchange rules or show they're getting stronger.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.